Ouster: Deal Hype Tripled The Stock. Q2 Won't Change The Valuation Problem.

Ouster (OUST) reports Q2 earnings in two days, and the headline from one camp is already set: margins won't budge much. The rival note nails that specific point. But it misses the bigger problem. Ouster's stock is up 130% in four months, trading at nearly 17 times revenue, while burning $65 million a year in free cash flow. The question isn't whether Q2 margins improve - they won't. The question is whether a valuation that has already tripled from its 52-week low is sustainable for a company that is deeply unprofitable and whose own management framework targets gross margins in the mid-30s to low-40s.

Downgrade: Avoid. Valuation has outrun execution.

The rally was deal headlines, not financial inflection

Ouster's stock has surged from $16.40 at its 52-week low to $46 right now, driven by a stack of announced partnerships and the "Physical AI" narrative. In June, the company struck a supply deal with AIM Intelligent Machines to put its Rev8 native-color lidar sensors on autonomous heavy construction and mining equipment. It expanded a manufacturing partnership with Benchmark Electronics to scale Rev8 production. It announced a collaboration with FieldAI to deploy autonomous perception in unstructured environments. The Rev8 lineup also cleared Build America, Buy America compliance, unlocking eligibility for federal infrastructure funding.

These are real developments. They validate demand for Ouster's next-generation digital lidar. But partnership announcements are not revenue. None of these deals showed up on Q1's income statement, where the company reported $48.6 million in revenue and a $17.5 million net loss. The market has priced in a multi-year revenue arc based on letters of intent and press releases, and it hasn't waited for proof.

The operating picture: growth without cash

Ouster's revenue is growing. Year-over-year, it's up 57%, and product revenue climbed 55% in Q1. The company achieved 13 consecutive quarters of product revenue growth and shipped over 12,600 lidar and camera sensors in Q1 alone. Management's long-term financial framework calls for 30% to 50% annual revenue growth, and the company has met or exceeded that target in recent quarters.

But the margin and cash flow numbers are what matter for valuation. Q1 GAAP gross margin was 43%, down 1,700 basis points from Q4 2025. Part of that drop is mechanical: Q4 included approximately $21 million in one-time IP license royalties that inflated that quarter's gross margin to 60%. Even stripping out the royalties, non-GAAP gross margin fell from 62% in Q4 to 46% in Q1. That's the Stereolabs acquisition - completed late in 2025 - dragging on blended margins. Stereolabs makes depth-sensing cameras, which carry lower margins than lidar.

Operating margin was -37.4% on a trailing twelve-month basis. Free cash flow margin was -37.4%. Free cash flow TTM was -$64.9 million, down 73% year-over-year. The company burns roughly $16 million per quarter in cash after capital expenditures.

Management has been clear about the path forward. Its framework targets 35% to 40% GAAP gross margins with operating expense growth held to 5-8% above 2025 levels. Those are the numbers to watch, not the headline revenue growth. At 43% gross margin in Q1, the company is above that target range, which suggests some runway. But the Stereolabs drag means margins will need deliberate work to climb, and the company has not yet demonstrated sustained operating leverage at this revenue scale.

What Q2 will - and won't - tell us

Consensus expects Q2 revenue of approximately $50.9 million, sitting near the middle of management's $49.5M-$52.5M guidance range. The quarter will include a full quarter of Stereolabs operations for the first time. That's good for revenue scale but unlikely to help the gross margin picture dramatically. Q2 EPS consensus is -$0.12 per share.

The competitor article is right that margins won't move the needle in Q2. The Stereolabs integration is still early, the Rev8 product ramp is just beginning to ship, and the AIM, FieldAI, and Benchmark deals are too new to show up as meaningful revenue. What Q2 will show is whether Ouster can hold its revenue trajectory at around $50 million per quarter without bleeding more cash. That's a baseline test, not a catalyst.

The real catalyst would be Q3 or Q4 guidance - the first window where Rev8 orders might actually convert to booked revenue and where the Stereolabs integration could start to stabilize. But at $46 per share and $3.1 billion market cap, the stock isn't priced for baseline execution. It's priced for acceleration.

The valuation problem

This is where the thesis breaks. Ouster trades at 16.7 times trailing revenue with an enterprise value of $2.9 billion. For context, the company's annualized revenue run rate is roughly $200 million. A $3 billion market cap on $200 million in revenue and -$65 million in annualized free cash flow is a growth stock premium of the highest order. The market is demanding that revenue triple and profitability arrive on schedule, or else the multiple comes crashing back.

Ouster's own management framework targets 35-40% gross margins. Even if the company hits the top of that range and achieves 50% revenue growth this year, that would put annual revenue near $300 million with pre-tax income still deeply negative given operating expenses. The path to profitability is real but distant - management has hinted at it within the next year, but the math requires both sustained revenue acceleration and aggressive operating discipline simultaneously.

Compare this to the cash burn. The company had approximately $175 million in cash, equivalents, and short-term investments as of March 31, 2026. At a $16 million per quarter burn rate, that's roughly 11 quarters of runway without raising capital or achieving cash-flow breakeven. The runway is adequate for now but not generous. If revenue growth stalls or integration costs exceed expectations, dilution becomes a real risk.

The 130% rally has compressed all of that execution risk out of the price. The stock went from a speculative, cash-burning hardware company with a $200 million revenue run rate to a $3 billion "Physical AI infrastructure" name. The narrative is compelling, the product roadmap is credible, and the partnerships are real. But the multiple assumes those partnerships convert to revenue quickly and margins expand predictably. That's a lot of assumption for a company whose Q1 EPS was still -$0.28.

What would change the call

A Q2 beat on both revenue and gross margin - say revenue above $52 million and gross margin above 48% - combined with upbeat Q3 guidance showing Rev8 revenue ramping would be the first evidence that this valuation has a foundation. A clear revenue inflection in Q3 or Q4 that accelerates past the 50% growth target while gross margins hold above 45% would also shift the risk/reward.

Conversely, a Q2 revenue miss below $49 million, a gross margin dip below 40%, or guidance that implies extended cash burn at current levels would expose how much future success this $3 billion market cap already reflects.

Verdict

Ouster is a company with real product momentum, a credible growth trajectory, and partnerships that could compound over the next two to three years. But the stock has moved ahead of the operating proof. At 17 times revenue with negative free cash flow, the margin for error is thin. Q2 won't change that equation, and neither will a single good quarter unless it comes with guidance that materially accelerates the path to profitability.

Rating: Downgrade to Avoid. Wait for Q2 results and Q3 guidance to show whether Rev8 orders are converting to revenue and whether the Stereolabs integration is stabilizing. The current price demands execution that the company hasn't demonstrated yet.